Embody vs He & She MD: Cheap compounded GLP-1 or coaching

Quick verdict: Embody vs He & She MD

The Embody vs He & She MD choice comes down to price and simplicity versus bundled coaching and multiformat options. Embody runs a lean, prescription-forward program with compounded semaglutide at $69/month and tirzepatide at $119/month plus free 1–2 day shipping. He & She MD starts semaglutide at $139/month with 1:1 clinician messaging, coaching, and tracking included, using six-month introductory rates that renew higher.

See Embody pricing and availability

Head-to-head comparison: five key differences

This direct comparison uses only stated facts to compare Embody and He & She MD across pricing, support, medication format and regulatory notes, shipping speed, and commitment terms.

Pricing and value: raw numbers and trade offs

Embody advertises compounded semaglutide at $69/month, reduced from $299, and compounded tirzepatide at $119/month. That is presented as the lowest entry price here. He & She MD advertises semaglutide from $139/month and tirzepatide from $199/month as six-month introductory rates that renew at higher six-month prices. If upfront monthly cost is the priority, Embody is the lower priced option. If bundled coaching and tracking are worth an introductory premium, He & She MD offers that at stated promo rates.

See He & She MD intro plans and app

Support and program design

Embody emphasizes a no-frills, telehealth prescription model with licensed provider review handled online, 24/7 support access for dosing and side effect questions, and fewer premium features. He & She MD bundles a coaching app that includes 1:1 clinician messaging, GLP-1-specific guidance, and progress tracking at no extra cost. Choose based on whether integrated coaching matters to your decision.

Medication formats and regulatory notes

Embody supplies compounded semaglutide and compounded tirzepatide only. He & She MD lists multiple formats: semaglutide injection, oral semaglutide, and tirzepatide injection. Both providers note that compounded medications are not reviewed by the FDA for safety, effectiveness or quality or that medications are produced in USP-compliant, state-regulated pharmacies but not reviewed by the FDA for safety, efficacy, or quality. Those regulatory qualifiers are stated by the providers.

Shipping and speed

Embody commits to free shipping that arrives in 1–2 days after clinician approval. He & She MD offers free expedited shipping and ships medication to your door. If faster post-approval delivery is decisive, Embody specifies a 1–2 day window.

Commitment length and renewal structure

Embody markets no monthly membership and cancel anytime with flat locked in monthly pricing, though final pricing may vary based on dose and clinician recommendation and the $69 semaglutide price is a limited-time offer that may increase. He & She MD sells plans as six-month introductory rates that renew at higher six-month prices. The He & She MD model requires budgeting for renewal prices rather than assuming the intro rate is permanent.

Check Embody availability now

Which to choose: final guidance on Embody vs He & She MD

Choose Embody if you want the lowest advertised entry price for compounded semaglutide at $69/month, compounded tirzepatide at $119/month, fast 1–2 day shipping after approval, and a no-membership, cancel-anytime structure. Choose He & She MD if you want bundled coaching, 1:1 clinician messaging, progress tracking in an app, and multiple medication formats with six-month introductory pricing that renews higher.

Get Embody pricing details

Explore He & She MD plans

Bottom line

For a direct EmBODY vs He & She MD comparison: Embody is the lower cost, no-frills compounded option with fast shipping and month-to-month cancelability. He & She MD bundles coaching and clinician access with multiformat options at six-month intro prices that renew higher. Evaluate whether price or integrated support matters more for your goals when choosing between Embody and He & She MD.